Genetic and structural determinants of virus neutralizing antibodies (original) (raw)

• Crowe JE Jr: Hostresponses to respiratory virus infection and immunization. Curr Top Microbiol Immunol 1999;236:191–214.
  PubMed CAS Google Scholar
• Crowe JE Jr: The role of antibodies in respiratory viral immunity. Sem Virol 1996;7:273–283.
  Article CAS Google Scholar
• Zhao X, Malashkevich VN, Kim PS: Structural characterization of the humanrespiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 2000;97:14,172–14,177.
  CAS Google Scholar
• Yuan W, Parrish CR: Comparison of twosingle-chainantihodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization. Virology 2000;269:471–480.
  Article PubMed CAS Google Scholar
• Outlaw MC, Dimmock NJ. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells. Virology 1993;195:413–421.
  Article PubMed CAS Google Scholar
• Edwards MJ, Dimmock NJ: Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgG siscomplex and occurs simulta neously through fusion inhibition and attachment inhibition. Virology 2000;278:423–435.
  Article PubMed CAS Google Scholar
• McInerney TL, McLain L, Armstrong SJ, Dimmock NJ: A human IgG1 (bl2) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusionentry process, but bl2 Fab neutralizes by inhibiting a postifusion event. Virology 1997;233:313–326.
  Article PubMed CAS Google Scholar
• Schroeder HW, Hillson JL, Perlmutter RM: Early restriction of the human antibody repertoire. Science 1987;238:791–793.
  Article PubMed CAS Google Scholar
• Brezinschek HP, Brezinschek RI, Lipsky PE: Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J Immunol 1995;155:190–202.
  PubMed CAS Google Scholar
• Rao SP, Riggs JM, Friedman DF, Scully MS, LeBien TW, Silberstein LE: Biused VH gene usage inearly lineage human B cells: evidence for preferential lg gene rearrangement in the absence of selection. J Immunol 1999;163:2732–2740.
  PubMed CAS Google Scholar
• Rajewsky K: Clonal selection and learning in the antibody system. Nature 1996;381:751–758.
  Article PubMed CAS Google Scholar
• Wisnewski A, Cavacini L, Posner M: Human antibody variable region gene usage in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:31–38.
  PubMed CAS Google Scholar
• Scamurra RW, Miller DJ, Dahl L, et al.: Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J Immunol 2000;164:5482–5491.
  PubMed CAS Google Scholar
• Messner BT, Sullivanu JJ, Chiorazzi N, Rodman TC, Thaler DS: Two human neonatal IgM antibodies encoded by different variableregion genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition. J Immunol 1999;162:2184–2192.
  Google Scholar
• Bagley J, Dillon PJ, Rosen C, Robinson J, Sodroski J, Marasco WA: Structural characterization of broadly neutra lizing human monocloral antibodies against the CD4 binding site of HIV-1 gp120. Mol Immunol 1994;31:1149–1160.
  Article PubMed CAS Google Scholar
• Llorente M, Sanchez-Palomino S, Manes S, et al.: Natural human antibodies retrieved by phage display libraries from healthy donors: polyreactivity and recognition of human immunodeficiency virus type 1 gp120 epitopes. Scand J Immunol 1999;50:270–279.
  Article PubMed CAS Google Scholar
• Lopez-Macias C, Kalinke U, Cascalho M, et al.: Secondary rearrangements and hypermulation generate sufficient B cell diversity to mount protective antiviral immunoglobulin responses. J Exp Med 1999;189:1791–1798.
  Article PubMed CAS Google Scholar
• Toran JL, Sanchez-Pulido L, Kremer L, del Real G, Valencia A, Martinez-A C: Improvement in affinity and HIV-1 neutralization by somatic mutation in the heavy chain first complementarity-determining region of antibodies triggered by HIV-1 infection. Eur J Immunol 2001;31:128–137.
  Article PubMed CAS Google Scholar
• Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF: CDR walkingmutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 1995;254:392–403.
  Article PubMed CAS Google Scholar
• Barbas CF, Hu D, Dunlop N, et al.: In vitro evolution of a neutralizing human antibody to human immun odeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci USA 1994;91:3809–3813.
  Article PubMed CAS Google Scholar
• Thompson, J, Pope T, Tung JS, et al: Afinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J Mol Biol 1996;256:77–88.
  Article PubMed CAS Google Scholar
• Roost HP, Bachmann MF, Haag A, et al.: Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc Natl Acad Sci USA 1995;92:1257–1261.
  Article PubMed CAS Google Scholar
• Crowe JE Jr., Murphy BR, Chanock RM, Williamson RA, Barbas CF III, Burton DR: Recombinant human R SV monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of respiratory syncytial virus-infected mice. Proc Natl Acad Sci USA 1994; 91:1386–1390.
  Article PubMed CAS Google Scholar
• Yoden S, Kida H, Yanagawa R: Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity. Arch Virol 1985;85:209–216.
  Article PubMed CAS Google Scholar
• Levi M, Sallberg M, Ruden U, et al.: A complementarity-determining region synthetic peptide acts as a miniantibody and neutralizes human immunodeficiency virus type 1 in vitro. Proc Natl Acad Sci USA 1993;90:4374–4378.
  Article PubMed CAS Google Scholar
• Bourgeois C, Bour JB, Aho LS, Potheir P: Prophylactic administration of a complementarity-determining region derived from a neutralizing monoclonal antibody is effective again strespiratory syncytial virus infection in BALB/c mice. J Virol 1998;72:807–810.
  PubMed CAS Google Scholar
• Kalike LI, Krebber A, Krebber C, et al.: Monovalent single-chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection. Eur J Immunol 1996;26: 2801–2806.
  Article Google Scholar
• Levi M, Hinkula J, Wahren B: A retro-inverso miniatibody with anti-HIV activity. AIDS Res Hum Retroviruses 2000;16:59–65.
  Article PubMed CAS Google Scholar
• Drake JW: Rates of spontaneous mutations among RNA viruses. Proc Natl Acad Sci USA 1993; 90:4171–4175.
  Article PubMed CAS Google Scholar
• Crowe JE Jr, Firestone C-Y, Beeler JA, Burton DR, Chanock RM, Murphy BR: Monoclonal antibody resistant mutants selected with an respiratory syncytial virus (RSV) neutralizing human antibody Fab fragment (Fab19) define a unique epitope on the fusion (F) glycoprotein. Virology 1998;252:373–375.
  Article PubMed CAS Google Scholar
• Hochleitner EO, Gomy MK, Zolla-Pazner S, Tomer KB: Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp1 20 recognized by the human monoclonal antibody 1331 A. J Immunol 2000; 164:4156–4161.
  PubMed CAS Google Scholar
• Jeyarajah S, Parker CE, Summer MT, Tomer KB: Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody. J Am Soc Mass Spectrom 1998;9:157–165.
  Article PubMed CAS Google Scholar
• Millar AL, Jackson NA, Dalton H, et al.: Rapid analysis of epitopeparatope interactions between HIV-1 and a 17-amino-acid neutralizing microantibody by electrospray ionization mass spectrometry. Eur J Biochem 1998;258:164–169.
  Article PubMed CAS Google Scholar
• Calder LJ, Gonzalez-Reyes L, Garcia-Barreno B, et al.: Electron microscopy of the human respiratory syncytial virus fusion, protein and complexes that if forms with monoclonal antibodies. Virology 2000;271:122–131.
  Article PubMed CAS Google Scholar
• Bizebard T, Gigant B, Rigolet P, et al.: Structure of influenza virus haemagglutinin complexed with a neutralizing antibody. Nature 1995;376:92–94.
  Article PubMed CAS Google Scholar
• Fleury D, Barrere B, Bizebard T, Daniels RS, Skehel JJ, Knossow M: A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 1999;6:530–534.
  Article PubMed CAS Google Scholar
• Murphy BR, Prince GA, Walsh EE, et al.: Dissociation between serum neutralizing and glyco proteinantibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol 1986;24: 197–202.
  PubMed CAS Google Scholar
• Sakurai H, Williamson RA, Crowe JE, et al.: Human antibody responses to mature and immuature forms of viral envelope in RSV infection: Significance for sub-unit vaccines. J Virol 1999;73:2956–2962.
  PubMed CAS Google Scholar
• Burton DR, Williamson RA, Parren PW: Antibody and virus: binding and neutralization. Virology 2000;270:1–3.
  Article PubMed CAS Google Scholar
• Osiowy C, Anderson R: Neutralization of respiratory syncytial virus after cell attachment. J Virol 1995;69:1271–1274.
  PubMed CAS Google Scholar
• Langedijk JPM, Meloen RH, van Oirschot JT: Identification of a conserved neutralization sitein the first hepatad repeat of the fusion protein of respiratory syncytial virus. Arch Virol 1998;143:313–320.
  Article PubMed CAS Google Scholar
• Jimenez-Clavero MA, Escribano-Romero E, Douglas AJ, Ley V: The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry. J Virol 2001;75:1044–1047.
  Article PubMed CAS Google Scholar
• Crowe JE Jr, Murphy BR, Chanock RM, et al.: Isolation of a second recombinant human respiratory syncytial virus (RSV) monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. J Inf Dis 1998;77: 1073–1076.
  Article Google Scholar
• Crowe JE Jr, Firestone C-Y, Murphy BR: Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated RSV vaccines. J Immunol 2001; in press.
• Crowe JE Jr, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR: Cold-passaged, temperature sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine 1995;13:847–855.
  Article PubMed Google Scholar
• Prince GA, Horswood RL, Chanock RM: Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol 1985;55:517–520.
  PubMed CAS Google Scholar
• Johnson S, Griego SD, Pfarr DS, et al.: A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZ19. J Infect Dis 1999;180:35–40.
  Article PubMed CAS Google Scholar
• Groothuis JR, Simoes EA, Levin MJ, et al.: Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 1993;329: 1524–1530.
  Article PubMed CAS Google Scholar
• Sami IR, Piazza FM, Johnson SA, et al.: Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats. J Infect Dis 1995;171:440–443.
  PubMed CAS Google Scholar
• Graham BS: Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol 1996;4:290–293.
  Article PubMed CAS Google Scholar
• Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG: Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 1992; 89:6901–6905.
  Article PubMed CAS Google Scholar
• Mazanec MB, Coudret CL, Fletcher DR: Intra cellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. J Virol 1995;69: 1339–1343.
  PubMed CAS Google Scholar
• Burns JW, Siadat-Pajouh M, Krishnaney AA, Greenberg HB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science 1996;272:104–107.
  Article PubMed CAS Google Scholar
• Bomsel M, Heyman M, Hocini H, et al.: Intracellular neutralization of HIV transcytosis across tight epithelial harriers by anti-HIV envelope protein dIgA or IgM. Immunity 1998;9:277–287.
  Article PubMed CAS Google Scholar